🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 17 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/04/2008 10,98 11,40 10,86 11,10 -0,54% 4,92% 60.183
01/04/2008 10,98 11,58 10,74 11,16 +1,09% 7,65% 68.933
31/03/2008 10,92 11,70 10,38 11,04 +4,55% 12,09% 129.183
28/03/2008 10,80 11,28 10,20 10,56 -0,56% 10,00% 55.083
27/03/2008 10,50 10,62 10,20 10,62 +2,91% 4,00% 40.500
26/03/2008 10,26 10,56 9,96 10,32 +1,78% 5,85% 77.817
25/03/2008 9,78 10,50 9,78 10,14 +5,63% 7,36% 105.200
24/03/2008 8,52 9,90 8,46 9,60 +11,89% 16,90% 124.533
20/03/2008 8,40 8,58 8,04 8,58 +0,70% 6,43% 29.967
19/03/2008 8,04 8,52 7,80 8,52 +4,41% 8,96% 64.433
18/03/2008 8,34 8,34 7,92 8,16 +2,26% 5,04% 27.000
17/03/2008 8,10 8,58 7,80 7,98 -3,62% 9,63% 25.967
14/03/2008 8,22 8,58 7,80 8,28 +0,00% 9,49% 65.800
13/03/2008 8,34 8,70 8,10 8,28 -0,72% 7,19% 68.650
12/03/2008 8,04 8,88 7,80 8,34 -3,47% 13,43% 79.667
11/03/2008 8,28 8,70 7,98 8,64 +5,88% 8,70% 63.067
10/03/2008 7,26 8,34 7,20 8,16 +8,80% 15,70% 84.733
07/03/2008 7,44 7,92 6,96 7,50 -2,34% 12,90% 61.983
06/03/2008 8,16 8,16 7,38 7,68 -4,48% 9,56% 58.933
05/03/2008 8,04 8,58 7,56 8,04 +0,75% 12,69% 44.050
04/03/2008 7,62 7,98 7,50 7,98 +6,40% 6,30% 20.717
03/03/2008 8,34 8,34 7,50 7,50 -8,09% 10,07% 48.250
29/02/2008 8,22 8,34 8,10 8,16 -2,16% 2,92% 22.633
28/02/2008 8,34 8,40 8,10 8,34 +0,00% 3,60% 29.733
27/02/2008 8,64 8,64 8,10 8,34 -3,47% 6,25% 32.967
26/02/2008 8,34 8,70 8,22 8,64 +1,41% 5,76% 31.200
25/02/2008 7,98 8,58 7,98 8,52 +5,19% 7,52% 38.100
22/02/2008 8,10 8,58 8,04 8,10 -2,17% 6,67% 36.517
21/02/2008 8,52 8,64 8,22 8,28 -4,17% 4,93% 36.767
20/02/2008 8,34 8,88 8,22 8,64 -1,37% 7,91% 53.367